Literature DB >> 21424364

[Initial experience with transoral robotic surgery using the da Vinci® surgical system].

C Simon1, B El-Baba, T Albrecht, F C Holsinger, P K Plinkert.   

Abstract

Transoral robotic surgery (TORS) can be considered an extension of transoral microscopic laser surgery. The microscope is replaced by an endoscope that provides the surgeon with a three-dimensional view of the surgical field. The surgeon operates from a console that controls the arms of the patient cart. These arms hold miniaturized surgical instruments that are transorally inserted into the patient, enabling tumor resection. Exposure is ensured by various mouth gags. The use of various endoscopes (0°, 30°), a work radius of 540° for instruments, and a zoom function provides significant advantages over the common transoral laser techniques. With this article we report our first experience with this technique and believe that it may provide significant advantages. However, thorough clinical testing in Germany is required before conclusions can be drawn.

Entities:  

Mesh:

Year:  2011        PMID: 21424364     DOI: 10.1007/s00106-010-2254-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  18 in total

1.  Transoral robotic surgery for parapharyngeal space tumors.

Authors:  Bert W O'Malley; Harry Quon; Fernando D Leonhardt; Ara A Chalian; Gregory S Weinstein
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2010-10-01       Impact factor: 1.538

2.  Transoral robotic surgery of the skull base: a cadaver and feasibility study.

Authors:  John Y K Lee; Bert W O'Malley; Jason G Newman; Gregory S Weinstein; Bradley Lega; Jason Diaz; M Sean Grady
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2010-07-29       Impact factor: 1.538

Review 3.  Transoral robotic surgery: does the ends justify the means?

Authors:  Gregory S Weinstein; Bert W O'Malley; Shaun C Desai; Harry Quon
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-04       Impact factor: 2.064

4.  Transoral robotic assisted free flap reconstruction.

Authors:  Vijay K Mukhija; Chih-Kwang Sung; Shaun C Desai; George Wanna; Eric M Genden
Journal:  Otolaryngol Head Neck Surg       Date:  2009-01       Impact factor: 3.497

5.  Transoral robotic free flap reconstruction of oropharyngeal defects: a preclinical investigation.

Authors:  Jesse C Selber; Geoff Robb; Joseph M Serletti; Gregory Weinstein; Randall Weber; F Christopher Holsinger
Journal:  Plast Reconstr Surg       Date:  2010-03       Impact factor: 4.730

6.  Transoral robotic reconstruction of oropharyngeal defects: a case series.

Authors:  Jesse C Selber
Journal:  Plast Reconstr Surg       Date:  2010-12       Impact factor: 4.730

7.  Transoral robotic surgery (TORS) for base of tongue neoplasms.

Authors:  Bert W O'Malley; Gregory S Weinstein; Wendy Snyder; Neil G Hockstein
Journal:  Laryngoscope       Date:  2006-08       Impact factor: 3.325

8.  Transoral robotic surgery for the management of head and neck cancer: a preliminary experience.

Authors:  Eric M Genden; Shaun Desai; Chih-Kwang Sung
Journal:  Head Neck       Date:  2009-03       Impact factor: 3.147

9.  Robotic skull base surgery: preclinical investigations to human clinical application.

Authors:  Bert W O'Malley; Gregory S Weinstein
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12

10.  Transoral robotic surgery: radical tonsillectomy.

Authors:  Gregory S Weinstein; Bert W O'Malley; Wendy Snyder; Eric Sherman; Harry Quon
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12
View more
  2 in total

1.  The Impact of HPV as an Etiological Factor in Gynecological and Oropharyngeal Cancer.

Authors:  Rafael Mañon; Veronica Schimp; Priya Gopalan; Kavita Pattani; Jennifer Tseng
Journal:  Am J Lifestyle Med       Date:  2015-02-12

2.  Transoral robotic surgery in Ireland: the beginning.

Authors:  Emma Keane; Isobel O'Riordan; Thomas Crotty; Justin M Hintze; Edlir Shytaj; Fergal O'Duffy; Tadgh P O'Dwyer; Tom Moran
Journal:  Ir J Med Sci       Date:  2021-02-09       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.